Century Therapeutics annual operating expenses
2020
2021
2022
2023
2024
2025
Century Therapeutics Operating Expenses Growth & History (IPSC)
Century Therapeutics's operating expenses was $126.4M for fiscal 2025.
View full Century Therapeutics company overviewCentury Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $126.4M | −$18.3M | −12.64% |
| 2024 | 2024-12-31 | $144.7M | −$4.1M | −2.73% |
| 2023 | 2023-12-31 | $148.8M | $9.8M | +7.01% |
| 2022 | 2022-12-31 | $139.0M | $44.1M | +46.53% |
| 2021 | 2021-12-31 | $94.9M | $41.0M | +76.04% |
| 2020 | 2020-12-31 | $53.9M | — | — |
Century Therapeutics quarterly operating expenses
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $36.5M | $1.9M | +5.37% |
| Q1 2026 | 2026-03-31 | $23.7M | −$11.3M | −32.31% |
| Q4 2025 | 2025-12-31 | $20.7M | −$20.8M | −50.17% |
| Q3 2025 | 2025-09-30 | $36.1M | $544,000 | +1.53% |
| Q2 2025 | 2025-06-30 | $34.7M | −$862,000 | −2.43% |
| Q1 2025 | 2025-03-31 | $35.0M | $2.8M | +8.78% |
| Q4 2024 | 2024-12-31 | $41.5M | −$2.6M | −5.85% |
| Q3 2024 | 2024-09-30 | $35.6M | −$194,000 | −0.54% |
| Q2 2024 | 2024-06-30 | $35.5M | $350,000 | +0.99% |
| Q1 2024 | 2024-03-31 | $32.2M | −$1.6M | −4.84% |
| Q4 2023 | 2023-12-31 | $44.0M | $10.2M | +30.16% |
| Q3 2023 | 2023-09-30 | $35.8M | $1.8M | +5.34% |
| Q2 2023 | 2023-06-30 | $35.2M | $2.4M | +7.42% |
| Q1 2023 | 2023-03-31 | $33.8M | −$4.7M | −12.19% |
| Q4 2022 | 2022-12-31 | $33.8M | $5.9M | +20.93% |
| Q3 2022 | 2022-09-30 | $34.0M | $8.1M | +31.50% |
| Q2 2022 | 2022-06-30 | $32.7M | $9.7M | +42.25% |
| Q1 2022 | 2022-03-31 | $38.5M | $20.4M | +113.12% |
| Q4 2021 | 2021-12-31 | $28.0M | — | — |
| Q3 2021 | 2021-09-30 | $25.8M | $12.7M | +96.69% |
| Q2 2021 | 2021-06-30 | $23.0M | $7.5M | +48.37% |
| Q1 2021 | 2021-03-31 | $18.1M | — | — |
| Q3 2020 | 2020-09-30 | $13.1M | — | — |
| Q2 2020 | 2020-06-30 | $15.5M | — | — |
Century Therapeutics operating expenses trends
Over the last five fiscal years, Century Therapeutics's operating expenses increased from $53.9M to $126.4M, a change of $72.5M. The latest reported quarter, Q2 2026, shows $36.5M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Century Therapeutics source filings ↗